<DOC>
	<DOCNO>NCT00952796</DOCNO>
	<brief_summary>On basis monotherapy intra-abdominal infection , investigator conduct study identify difference drug efficacy ampicillin/sulbactam moxifloxacin .</brief_summary>
	<brief_title>A Comparative Study Ampicillin/Sulbactam Versus Moxifloxacin Treatment Complicated Intra-abdominal Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Sultamicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>patient diagnose complicated intraabdominal infection need surgical treatment patient diagnose intraabdominal infection receive nonoperative management patient know allergic history fluoroquinolone Severe , life threaten disease life expectancy &lt; 48 h APS APACHE score &gt; 35</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>intra-abdominal infection</keyword>
	<keyword>moxifloxacin</keyword>
	<keyword>ampicillin/sulbactam</keyword>
</DOC>